The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gender representation in first and senior authorship of phase III solid-tumor trials presented at the ASCO Annual Meeting, 2015-2025.
 
Sarbajit Mukherjee
Consulting or Advisory Role - BeiGene; Boehringer Ingelheim; Bristol Myers Squibb Foundation; Eisai; Gilead Sciences; Incyte; Merck; Natera
Research Funding - Ipsen (Inst)
Other Relationship - Esophageal Cancer Action Network (ECAN)
 
Azza Sarfraz
No Relationships to Disclose
 
Shree Rath
No Relationships to Disclose
 
Sarah Abraham
No Relationships to Disclose
 
Lydia Hodgson
No Relationships to Disclose
 
Zouina Sarfraz
No Relationships to Disclose
 
Sawyer Bawek
No Relationships to Disclose
 
Fatma Nihan Akkoc Mustafayev
No Relationships to Disclose
 
Khalid Qidwai
No Relationships to Disclose
 
Kyaw Aung
No Relationships to Disclose
 
Manmeet Ahluwalia
Stock and Other Ownership Interests - doctible; Live AI; MedInnovate Advisors LLC; MimiVax; Modifi Bio; TriSalus Life Sciences
Consulting or Advisory Role - AlloVir; Apollomics; Autem Therapeutics; Bayer; Bugworks; Equillium; GT Medical Technologies; Incyte; Menarini Group; Modifi Bio; Pyramid Biosciences; Recordati; SERVIER; Sumitomo Dainippon Pharma Oncology; VBI Vaccines; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)